1 Indian Peptides Market Overview (Page No. – 11)
1.1 Introduction
1.2 Indian Peptides Market Dynamics
1.2.1 Drivers
1.2.1.1 Rising Incidence of Diseases
1.2.1.2 Favorable Government Initiatives for the Pharmaceutical Sector
1.2.2 Restraint
1.2.2.1 Availability of Alternative Drugs
1.2.3 Opportunity
1.2.3.1 Patent Expiry of Blockbuster Peptides
1.2.4 Challenge
1.2.4.1 Regulatory and Pricing Issues
2 Indian Peptides Market, By Type (Page No. – 16)
2.1 Introduction
2.2 Insulin
2.2.1 Insulin Market : Companies With Pipeline Product
2.3 Teriparatide
2.3.1 Teriparatide Acetate Market: Companies With Pipeline Products
2.4 Liraglutide
2.5 Leuprolide Acetate
2.5.1 Leuprolide Acetate Market: Companies With Pipeline Products
2.6 Octreotide Acetate
2.7 Calcitonin-Salmon
2.8 Triptorelin
2.9 Eptifibatide
2.10 Glatiramer Acetate
2.11 Bivalirudin
2.12 Glucagon
2.13 Exenatide
2.13.1 Exenatide Market: Companeis With Pipeline Products
2.14 Other Molecules
3 Indian Peptides Market, By Application (Page No. – 32)
3.1 Introduction
3.2 Diabetes
3.3 Infectious Diseases
3.4 Cancer
3.5 Osteoporosis
3.6 Cardiology
3.7 Gynecology
3.8 Other Applications
4 Indian Peptides Market Share Analysis (Page No. – 36)
5 Indian Peptides Market Company Profiles (Page No. – 37)
(Business Overview, Products Offered)*
5.1 Biocon Limited
5.2 Sun Pharmaceutical Industries Ltd.
5.3 Wockhardt Ltd.
5.4 Intas Pharmaceuticals Ltd.
5.5 Cipla Limited
5.6 Emcure Pharmaceuticals Pvt. Ltd.
5.7 Zydus Cadila
5.8 Bharat Serum and Vaccines Limited
5.9 Natco Pharma Limited
5.10 Dr. Reddy’s Laboratories
*Details on Marketsandmarkets View, Business Overview, Products Offered Might Not Be Captured in Case of Unlisted Companies.
6 Indian Heparin Market Overview (Page No. – 53)
6.1 Introduction
6.2 Indian Heparin Market Dynamics
6.2.1 Drivers
6.2.1.1 Growing Incidence of Coagulation Disorders
6.2.1.2 Government Support for the Pharmaceutical Industry
6.2.2 Restraint
6.2.2.1 High Degree of Consolidation to Hinder Small Players From Entering the Market
6.2.3 Challenge
6.2.3.1 Regulatory and Pricing Issues
7 Indian Heparin Market, By Type (Page No. – 57)
7.1 Introduction
7.2 Enoxaparin Sodium
7.2.1 Enoxaparin Sodium Market: Companies With Pipeline Products
7.3 Heparin Sodium
7.4 Fondaparinux
7.4.1 Fondaparinux Market: Companies With Pipeline Products
7.5 Dalteparin Sodium
7.5.1 Dalteparin Sodium Market: Companies With Pipeline Products
8 Indian Heparin Market Share Analysis (Page No. – 63)
9 Indian Heparin Market Company Profiles (Page No. – 64)
(Business Overview, Products Offered)*
9.1 Cipla Ltd.
9.2 Emcure Pharmaceuticals Pvt. Ltd.
9.3 Gland Pharma Limited
9.4 Troikaa Pharmaceuticals Ltd.
9.5 Biological E Limited
9.6 Bharat Biotech
9.7 Samarth Life Sciences Pvt. Ltd.
9.8 VHB Life Sciences Limited
9.9 Celon Laboratories Pvt. Ltd.
9.10 United Biotech (P) Limited
*Details on Marketsandmarkets View, Business Overview, Products Offered Might Not Be Captured in Case of Unlisted Companies.
9.11 Author Details
Table 1 Incidence of Cancer Cases in India, 2015 vs 2025
Table 2 Peptides and Their Alternatives
Table 3 Indian Peptides Market, By Type, 2016–2022 (USD Million)
Table 4 Insulin Market: Manufacturers and Brands
Table 5 Insulin Market: Key Players and Brands
Table 6 Teriparatide Acetate Market: Manufacturers and Brands
Table 7 Teriparatide Acetate Market: Key Players and Brands
Table 8 Liraglutide Market: Key Players and Brands
Table 9 Leuprolide Acetate Market: Manufacturers and Brands
Table 10 Leuprolide Acetate Market: Key Players and Brands
Table 11 Octreotide Acetate Market: Manufacturers and Brands
Table 12 Octreotide Acetate Market: Key Players and Brands
Table 13 Calcitonin-Salmon Market: Manufacturers and Brands
Table 14 Calcitonin-Salmon Market: Key Players and Brands
Table 15 Triptorelin Market: Manufacturers and Brands
Table 16 Triptorelin Market: Key Players and Brands
Table 17 Eptifibatide Market: Manufacturers and Brands
Table 18 Eptifibatide Market: Key Players and Brands
Table 19 Glatiramer Acetate Market: Manufacturers and Brands
Table 20 Glatiramer Acetate Market: Key Players and Brands
Table 21 Bivalirudin Market: Manufacturers and Brands
Table 22 Bivalirudin Market: Key Players and Brands
Table 23 Glucagon Market: Key Players and Brands
Table 24 Exenatide Market: Key Players and Brands
Table 25 Colistin Molecule: Manufactureres and Brands
Table 26 Colistin Market: Key Players and Brands
Table 27 Enalapril Molecule: Manufactureres and Brands
Table 28 Enalapril Market: Key Players and Brands
Table 29 Caspofungin: Manufactureres and Brands
Table 30 Caspofungin Market: Key Players and Brands
Table 31 Bortezomib: Manufactureres and Brands
Table 32 Bortezomib Market: Key Players and Brands
Table 33 Oxytocin: Manufacturers and Brands
Table 34 Oxytocin Market: Key Players and Brands
Table 35 Indian Peptides Market Size, By Application, 2016–2022 (USD Million)
Table 36 Incidence of Cancer Cases in India, 2015 vs 2025
Table 37 Indian Heparin Market, By Type, 2016–2022 (USD Million)
Table 38 Enoxaparin Sodium Market: Manufacturers and Brands
Table 39 Enoxaparin Sodium Market: Key Players and Brands
Table 40 Heparin Sodium Market: Manufacturers and Brands
Table 41 Heparin Sodium Market: Key Players and Brands
Table 42 Fondaparinux Market: Manufacturers and Brands
Table 43 Fondaparinux Market: Key Players and Brands
Table 44 Dalteparin Sodium Market: Manufacturers and Brands
Table 45 Dalteparin Sodium Market: Key Players and Brands
List of Figures (15 Figures)
Figure 1 Indian Peptides Market: Drivers, Restraints, Opportunities, and Challenges
Figure 2 Drug Approvals in India
Figure 3 Other Molecules: Market Share, 2016
Figure 4 Indian Peptides Market Share, By Key Player, 2016
Figure 5 Company Snapshot: Biocon Limited (2016)
Figure 6 Company Snapshot: Sun Pharmaceutical Industries Ltd (2016)
Figure 7 Company Snapshot: Wockhardt Ltd. (2016)
Figure 8 Company Snapshot: Intas Pharmaceuticals Ltd (2016)
Figure 9 Company Snapshot: Cipla Limited(2016)
Figure 10 Company Snapshot: Zydus Cadila (2016)
Figure 11 Company Snapshot: Natco Pharma Limited (2016)
Figure 12 Company Snapshot: Dr. Reddy’s Laboratories (2016)
Figure 13 Indian Heparin Market: Drivers, Restraints, and Challenges
Figure 14 Indian Heparin Market Share, By Key Player, 2016
Figure 15 Company Sanpshot: Cipla Ltd.
【レポートのキーワード】
ペプチド、ヘパリン、インド、インシュリン、テリパラチド、ロイプロリド、ロイプロリド、エキセナチド、カルシトニン、、ヘパリン・ナトリウム
